DE3855078D1 - Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode - Google Patents

Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode

Info

Publication number
DE3855078D1
DE3855078D1 DE3855078T DE3855078T DE3855078D1 DE 3855078 D1 DE3855078 D1 DE 3855078D1 DE 3855078 T DE3855078 T DE 3855078T DE 3855078 T DE3855078 T DE 3855078T DE 3855078 D1 DE3855078 D1 DE 3855078D1
Authority
DE
Germany
Prior art keywords
cystatin
producing
carrying
modifications
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3855078T
Other languages
English (en)
Other versions
DE3855078T2 (de
Inventor
Anders Grubb
Ake Lundwall
Magnus Abrahamson
Henrik Dlaboge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dako Denmark ApS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of DE3855078D1 publication Critical patent/DE3855078D1/de
Publication of DE3855078T2 publication Critical patent/DE3855078T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE3855078T 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode Expired - Lifetime DE3855078T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden
PCT/DK1988/000082 WO1988009384A1 (en) 1987-05-22 1988-05-20 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method

Publications (2)

Publication Number Publication Date
DE3855078D1 true DE3855078D1 (de) 1996-04-11
DE3855078T2 DE3855078T2 (de) 1996-07-18

Family

ID=8113675

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3855078T Expired - Lifetime DE3855078T2 (de) 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode

Country Status (12)

Country Link
EP (1) EP0362259B1 (de)
JP (1) JP3011274B2 (de)
AT (1) ATE135049T1 (de)
AU (1) AU619750B2 (de)
CA (1) CA1340862C (de)
DE (1) DE3855078T2 (de)
DK (1) DK260987D0 (de)
ES (1) ES2013337A6 (de)
FI (1) FI102191B1 (de)
IL (1) IL86476A (de)
NO (1) NO301985B1 (de)
WO (1) WO1988009384A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002820A1 (en) * 1988-11-18 1990-05-18 Kazunori Hanada Pharmaceutical use for cystatins
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
RU2182598C2 (ru) * 1994-11-21 2002-05-20 Новартис Аг Модифицированные ингибиторы протеиназы
AU738766B2 (en) * 1994-11-21 2001-09-27 University Of Leeds, The Modified proteinase inhibitors
EP0842187A4 (de) * 1995-06-05 2000-04-12 Human Genome Sciences Inc Humancystanin e
US6011012A (en) 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
EP1123399A2 (de) * 1998-08-05 2001-08-16 The University Of British Columbia Herstellung und verwendung von modifizierten cystatinen
US6436389B1 (en) * 1998-12-11 2002-08-20 The Salk Institute For Biological Studies Stimulation of cell proliferation by glycosylated cystatin C
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
EP2880994B1 (de) * 2012-07-31 2017-06-28 Megmilk Snow Brand Co. Ltd. Neuartiges proteinmaterial
CN102895658A (zh) * 2012-08-23 2013-01-30 苏州大学附属第一医院 Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) * 2016-08-10 2016-11-16 吴江近岸蛋白质科技有限公司 表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
DE3855078T2 (de) 1996-07-18
NO301985B1 (no) 1998-01-05
JP3011274B2 (ja) 2000-02-21
WO1988009384A1 (en) 1988-12-01
IL86476A0 (en) 1988-11-15
AU619750B2 (en) 1992-02-06
FI895553A0 (fi) 1989-11-21
IL86476A (en) 1994-01-25
ES2013337A6 (es) 1990-05-01
JPH03501201A (ja) 1991-03-22
EP0362259B1 (de) 1996-03-06
ATE135049T1 (de) 1996-03-15
NO890260L (no) 1989-01-20
EP0362259A1 (de) 1990-04-11
DK260987D0 (da) 1987-05-22
AU1939988A (en) 1988-12-21
NO890260D0 (no) 1989-01-20
FI102191B (fi) 1998-10-30
CA1340862C (en) 1999-12-28
FI102191B1 (fi) 1998-10-30

Similar Documents

Publication Publication Date Title
DE3855078D1 (de) Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
DE68928934D1 (de) Verfahren zur herstellung von menschlicher dnase
DE3884435T2 (de) Verfahren zur Erzeugung hochreinen Wassers und Verfahren zur Verwendung dieses Wassers.
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE3880438T2 (de) Verfahren zur Herstellung von Aktivkohle.
DE3583194D1 (de) Verfahren zur herstellung von einem polypeptid mittels eines transformierten mikroorganismus, ein dazu geeigneter transformierter mikroorganismus, und zur herstellung dieser mikroorganismen geeignete dns sequenzen.
DE3177213D1 (de) Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
PL272698A1 (en) Method for expressing human proapolyprotein a-j
DE69332520T2 (de) Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
IL107642A0 (en) Progenitor b cell stimulating factor
DE3688336T2 (de) Verfahren zur Herstellung von organischen Säuren unter Verwendung von Mikroorganismen.
DE3885151T3 (de) Methode zur Herstellung von Methacrylatestern.
DE3767680D1 (de) Methode zur herstellung von adiponitril.
DE3680632D1 (de) Verfahren zur herstellung von kohlenstoffasern und diese kohlenstoffasern.
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
DE3882453T2 (de) Verfahren zur Herstellung von Ibuprofen.
DE68914956D1 (de) Methode zur Herstellung von Dialkyl- und Diallyldicarbonaten.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
DE3864372D1 (de) Verfahren zur herstellung von 1-aryl-alk-1-enen.
DE3761088D1 (de) Verbessertes verfahren zur herstellung von p-cymol und homologen alkylbenzolen.
ATE45968T1 (de) Verfahrung zur herstellung von ungesaettigen polyestern.
DE3582368D1 (de) Verfahren zur herstellung von epoxyden mittels mikroorganismen.
ATE56363T1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
DE3786870T2 (de) Methode zur Herstellung von Proteinen.
DE3884324T2 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAKO A/S, GLOSTRUP, DK

8327 Change in the person/name/address of the patent owner

Owner name: DAKO DENMARK A/S, GLOSTRUP, DK